Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-585-0 | CAS number: 12013-46-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2 mg/m³
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2 mg/m³
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 5.7 mg/kg bw/day
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 5.7 mg/kg bw/day
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Additional information - workers
For acute DNEL-systemic effects, based on "Guidance on information requirements and chemical safety assessment Chapter R.8: Characterisation of dose [concentration]-response for human health", generally systemic effects after acute oral and dermal exposure should in a first tier be assessed using the corresponding long-term DNELs. A DNEL for acute toxicity is only established for the effects of peak exposures as these peaks can be significantly higher than the average daily exposure and the long-term DNEL (to be complied with on average over e.g. a working day) may be insufficient to limit them. To tin dioxide, no such peak exposure existed, so long term DNELs is sufficient and also directly used as acute DNELs-systemic effects.
For DNEL -local effects, the substance was not as an irritant to eye and skin, so the DNEL is unnecessary to be generated for local effects.
For long-term DNEL – systemic effects (dermal) from the toxicokinetics assessment for tin dioxide a maximum of 5 % dermal absorption rate has been considered based on guidance. For derivation of the long-term systemic dermal DNEL, on one hand the oral NOAEL = 40 mg/kg bw/d (Sn2+) was converted into a corrected dermal NOAEL of 800 mg/kg bw/d (5 % dermal absorption rate for tin dioxide, and all absorbed tin was assumed to be converted to Sn2+) according to the procedure, recommended in the current guidance document (R8, ECHA 2010). The following assessment factors (AF) were applied: •allometric scaling = 4 (R8, ECHA 2010) •remaining differences = 2.5 (R8, ECHA 2010) •intraspecies = 5 (for work R8, ECHA 2010) •exposure duration = 1 (since the NOAEL was derived from a multi-generation test) •quality of whole database = 1 (based on validity of studies performed). Total AF = 4 x 2.5 x 5 x 1 x 1 = 50. => Consequently, the dermal long-term systemic DNEL derived for workers was 800 / 50 = 16 mg/kg bw/day.
On the other hand, the occupational exposure limit for tin inorganic tin was published by German Committee on Hazardous Substances (Ausschuss für Gefahrstoffe – AGS) as Arbeitsplatzgrenzwerte – AGW. The value published is 2 mg/m3which can be taken as start point to calculate the DNEL. 8 hours inhalation volume is 10 m3for worker with body weight of 70 kg (R8, ECHA 2010).5 % dermal absorption rate was assumed for tin dioxide. The converted reference value for dermal exposure was calculated as 2 x 10/5%/70 = 5.7 mg/kg bw.Since the start point is an occupational exposure limit, the AF can be assumed as 1. Therefore the long-term systemic DNEL (dermal) derived for workers was5.7 mg/kg bw by this method. Pragmatically the lower one was chosen as the long-term systemic DNEL (dermal) derived for workers in risk assessment, 5.7 mg/kg bw.
For long-term DNEL – systemic effects (Inhalation), there are no data on inhalation toxicity. However the occupational exposure limit for tin inorganic tin was published by German Committee on Hazardous Substances (Ausschuss für Gefahrstoffe – AGS) as Arbeitsplatzgrenzwerte – AGW. The value published is 2 mg/m3.Since the start point is an occupational exposure limit, the AF can be assumed as 1. Therefore the long-term systemic DNEL derived for workers directly was 2 mg/m3.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 6 mg/m³
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 6 mg/m³
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2 mg/kg bw/day
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2 mg/kg bw/day
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2 mg/kg bw/day
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2 mg/kg bw/day
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
General Population - Hazard for the eyes
Additional information - General Population
For acute DNEL-systemic effects, based on "Guidance on information requirements and chemical safety assessment Chapter R.8: Characterisation of dose [concentration]-response for human health", generally systemic effects after acute oral and dermal exposure should in a first tier be assessed using the corresponding long-tem DNELs. A DNEL for acute toxicity is only established for the effects of peak exposures as these peaks can be significantly higher than the average daily exposure and the long-term DNEL (to be complied with on average over e.g. a working day) may be insufficient to limit them. To tin dioxide, no such peak exposure existed, so long term DNELs is sufficient and also directly used as acute DNELs-systemic effects.
For DNEL -local effects, the substance was not as an irritant to eye and skin, so the DNEL is unnecessary to be generated for local effects.
From the toxicokinetics assessment for tin dioxide a maximum of 5 % dermal and oral absorption rates have been considered based on guidance. For derivation of the long-term systemic dermal and oral DNELs, on one hand the oral NOAEL = 40 mg/kg bw/d (Sn2+) was converted into a corrected dermal/oral NOAEL of 800 mg/kg bw/d (5 % dermal absorption rate for tin dioxide, and all absorbed tin was assumed to be converted to Sn2+) according to the procedure, recommended in the current guidance document (R8, ECHA 2008). The following assessment factors (AF) were applied: •allometric scaling = 4 (R8, ECHA 2010) •remaining differences = 2.5 (R8, ECHA 2010) •intraspecies = 10 (for general population R8, ECHA 2010) •exposure duration = 1 (since the NOAEL was derived from a multi-generation test) •quality of whole database = 1 (based on validity of studies performed). Total AF = 4 x 2.5 x 10 x 1 x 1 = 100. => Consequently, the oral and dermal long-term systemic DNELs derived for general population was 800 / 100 = 8 mg/kg bw/day. On the other hand, Tin was previously evaluated for tolerable intake for humans by JECFA in 1966, 1970, 1971, 1975, 1978, and 1982. A provisional maximum tolerable daily intake of 2 mg of tin per kg bw was established by the committee. Since the same absorption rate (5%) was assumed to both oral and dermal routs, the provisional maximum tolerable daily intake of 2 mg/kg bw was directly used as a long-term DNEL – systemic effects (oral and dermal). Pragmatically the lower one was chosen as the long-term systemic DNEL derived for general population via both oral and dermal routes in risk assessment, 2 mg/kg bw.
There are no data on inhalation toxicity. Considering a provisional maximum tolerable daily intake of 2 mg of tin per kg bw was established by the committee, this value can be used as a start point to calculate the long-term inhalation route-systemic effects (general population). The body weight is 60 kg for general population. 24 hours respiration volume: 20 m3/person. In addition, since the start point is a TDI, the AF can be assumed to be 1. DNEL (chronic, general population) = 2 x 60/20 = 6 mg/m3.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.